Matches 51 - 100 out of 291 < 1 2 3 4 5 6 >
Match Document Document Title
6432381 Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract  
Particulate crystalline therapeutic substances are formulated with stabilizers to enhance contact between the crystalline therapeutic substances and the mucosal membranes to provide extended...
6426091 Sustained-release theophylline tablet  
A theophylline sustained release tablet obtained by coating core granules composed mainly of theophylline with a layer of a coating film composed of a hydrophobic material and a plastic excipient...
6380234 Stabilized pharmaceutical composition and its production  
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl,...
6379706 Rapidly disintegrating coated pellets with delayed release  
The invention concerns pharmaceutical forms of administration that are in the form of pellets which contain a retarding agent in which the release rate of the active substance is not delayed or is...
6326027 Controlled release formulation  
A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
6312728 Sustained release pharmaceutical preparation  
The present invention pertains to a sustained release drug delivery system which comprises a core of active ingredient, an enteric coating, a second coating of active ingredient and lastly a...
6306900 Enteric coated pharmaceutical compositions  
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
6296875 Method for producing a granule  
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy,...
6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole  
An oral pharmaceutical composition comprises an acid-labile irreversible proton pump inhibitor in pellet or tablet form, wherein the irreversible proton pump inhibitor is at least partly in...
6270804 Sachet formulations  
Bioaffecting sachets, or powders, containing coated liquiflash microspheres and partially recrystallized shearform floss particles are disclosed. The sachets give organoleptically acceptable...
6267989 Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions  
The present invention is directed to methods for preventing crystal growth and particle aggregation in nanoparticulate compositions. The methods comprise reducing a nanoparticulate composition to...
6258343 Method for encapsulating reactive dental agents  
A method for encapsulating a water soluble reactive agent in an alkyl cellulosic polymer to provide an encapsulated product from which leaching of the reactive agent into an aqueous dentifrice...
6254887 Controlled release tramadol  
A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
6251429 Programmed release ambroxol--HCl dosage forms  
Programmed-release ambroxolHCl pharmaceutical dosage forms, adopted to maintain a therapeutically effective plasma level thereof for about 24 hours, comprise a plurality of inert core...
6245351 Controlled-release composition  
A controlled-release composition comprising a drug-containing core coated with a coating composition containing a water-insoluble substance and a swellable polymer having no basic groups which is...
6238703 Controlled release oral dosage form of ketoprofen  
A controlled release analgesic dosage form comprising: a core comprising an analgesic and binding agent; and a coating comprising an enteric polymer, a water insoluble second polymer and a lubricant.
6224909 Fast decomposing pellets  
The invention concerns pharmaceutical forms of administration that are in the form of pellets which contain a retarding agent in which the release rate of the active substance is not delayed or is...
6221402 Rapidly releasing and taste-masking pharmaceutical dosage form  
A rapidly-releasing and taste-masking pharmaceutical dosage form and a process for preparing such oral dosage form are disclosed.
6214386 Prompt-release oral pharmaceutical compositions for extemporaneous suspensions  
A pharmaceutical composition suitable for preparing an extemporaneous suspension, that promptly releases active agents or ingredients (drugs) is disclosed. These compositions comprise an active...
6207197 Gastroretentive controlled release microspheres for improved drug delivery  
There is provided a drug delivery composition for the controlled release of an active agent in the stomach environment over a prolonged period of time, which comprises a microsphere comprising an...
6197347 Oral dosage for the controlled release of analgesic  
An oral dosage form that provides for the controlled release of an analgesic wherein the dosage form comprises a core containing an analgesic that is coated with a mixture of an enteric polymer, a...
6172107 Entric-coated pharmaceutical compositions  
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
6168806 Orally administrable nifedipine pellet and process for the preparation thereof  
The present invention relates to a fast-release as well as a prolonged release type of nifedipine pellets and the process for the preparation thereof. The fast-release type of nifedipine pellets...
6165514 Methods of enhancing repair, healing and augmentation of tissues and organs  
Tissue and organ repair, healing and augmentation are enhanced by administering pharmaceutically acceptable group IIIa element-containing compounds in amounts sufficient to provide therapeutic...
6165512 Dosage forms containing taste masked active agents  
The invention relates to compositions useful for making taste-masked oral dosage forms which can be easily processed and which disintegrate rapidly when placed in the mouth. The compositions...
6143322 Method of treating humans with opioid formulations having extended controlled release  
Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24...
6139865 Taste-masked microcapsule compositions and methods of manufacture  
A taste-masked microcapsule composition for administration of a drug is provided. The composition comprises microcapsules of drug and a substantially water-insoluble polymeric material, typically a...
6136347 Flavor-masked pharmaceutical compositions  
The invention relates to flavor-masked pharmaceutical compositions for oral administration, their preparation and their use as medicaments. The new pharmaceutical preparations according to the...
6126967 Extended release acetaminophen particles  
An extended release acetaminophen composition comprises a plurality of discrete particles containing acetaminophen which, when contained within a gelatin capsule and assayed in a USP Apparatus I...
6123962 Process for producing stabilized pharmaceutical composition  
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula ##STR1## wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy,...
6117452 Fatty ester combinations  
The thermoforming of compositions containing active agents is carried out by processing compositions containing certain fatty esters in combination.
6110501 Seeded microcapsules for use in tablets, pharmaceutical agents and nutritional compounds  
A microcapsule having a core, a shell and seeds fully or partially embedded in said shell. The core and seeds are active substances which preferably function as a leavening agent. The shell is...
6103261 Opioid formulations having extended controlled release  
Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24...
6099865 Croscarmellose taste masking  
The present invention describes the use of croscarmellose sodium to coat bitter-tasting active agents in a manner that will mask the bitter taste of these materials, taste masked pharmaceutical...
6090412 H.sub.2 -Receptor antagonist and antacid composition  
A solid pharmaceutical composition for oral administration comprising a histamine H 2 -receptor antagonist, a low neutralizing capacity antacid, and a high neutralizing capacity antacid coated...
6077542 Solid substances comprising valproic acid and sodium valproate  
Substances that are solid at 25° C. are obtained by dissolving sodium valproate in heated valproic acid and cooling the resultant solution. The resulting solid substances can easily be processed...
6056970 Compositions comprising hemostatic compounds and bioabsorbable polymers  
Solid, fibrous bioabsorbable hemostatic compositions containing a bioabsorbable polymer and a hemostatic compound, methods for making the hemostatic compositions, and methods for using the...
6025391 Enteric-coated pharmaceutical compositions of mycophenolate  
6015577 Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation  
The specification describes a pharmaceutical combination consisting of dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing...
6004581 Modified release oral pharmaceutical composition and method for the treatment of bowel diseases  
Modified release pharmaceutical composition and method for the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease and Colitis Ulccrosa, said compositions comprising as active...
5980952 Pharmaceutical composition for the programmed release of dexfenfluramine  
A novel pharmaceutical composition allowing the programmed release of dexfenfluramine containing a water-soluble acid addition salt of dexfenfluramine on a mixture of minigranules, both rapid...
5976507 Dentrifice composition containing encapsulated reactive ingredients  
An aqueous dentifrice composition comprising an aqueous vehicle containing at least two active ingredients reactive with each other, at least one of the active ingredients being encapsulated in a...
5958459 Opioid formulations having extended controlled released  
Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24...
5955104 Multiple unit oral pharmaceutical formulations  
A multiple unit oral pharmaceutical dosage form having a plurality of pellets in a water soluble capsule or in a tablet compressed from the pellets, wherein each pellet contains (a) a substantially...
5885616 Sustained release drug delivery system suitable for oral administration  
A single bead drug delivery system suitable for oral administration with multiply layered drug and polymer compartments can provide a two-step release of active agent to facilitate an immediate yet...
5885611 Bandage-forming gel for oral mucosa  
A method of administering an oral bandage to lesions in the oral mucosa is disclosed wherein there is prepared a storage stable topical gel formulation adapted to form an oral bandage adherent to...
5858410 Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution  
Provided is a drug carrier comprising particles of at least one pure active compound which is insoluble, only sparingly soluble or moderately soluble in water, aqueous media and/or organic...
5840332 Gastrointestinal drug delivery system  
A gastrointestinal delivery system is provided. The system comprises a drug in combination with a core material, the core being surrounded by a water-insoluble or relatively water-insoluble coating...
5834021 Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease  
The dissolution at pH 6.5 of prednisolone metasulphobenzoate or a pharmacologically acceptable salt thereof from a non-disintegratable solid enteric composition comprising the prednisolone...
5817340 Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide  
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a therapeutically effective amount of guanidinothiazole compound; and a...
Matches 51 - 100 out of 291 < 1 2 3 4 5 6 >